Cargando…

Conflict of interest among Italian medical oncologists: a national survey

OBJECTIVES: To assess Italian medical oncologists’ opinion on the implications of conflict of interest (COI) on medical education, care and research, and to evaluate their direct financial relationships. DESIGN: National cross-sectional survey conducted between March and April 2017 among Italian onc...

Descripción completa

Detalles Bibliográficos
Autores principales: DeCensi, Andrea, Numico, Gianmauro, Ballatori, Enzo, Artioli, Fabrizio, Clerico, Mario, Fioretto, Luisa, Livellara, Virginia, Ruggeri, Benedetta, Tomirotti, Maurizio, Verusio, Claudio, Roila, Fausto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042593/
https://www.ncbi.nlm.nih.gov/pubmed/29961019
http://dx.doi.org/10.1136/bmjopen-2017-020912
_version_ 1783339186903842816
author DeCensi, Andrea
Numico, Gianmauro
Ballatori, Enzo
Artioli, Fabrizio
Clerico, Mario
Fioretto, Luisa
Livellara, Virginia
Ruggeri, Benedetta
Tomirotti, Maurizio
Verusio, Claudio
Roila, Fausto
author_facet DeCensi, Andrea
Numico, Gianmauro
Ballatori, Enzo
Artioli, Fabrizio
Clerico, Mario
Fioretto, Luisa
Livellara, Virginia
Ruggeri, Benedetta
Tomirotti, Maurizio
Verusio, Claudio
Roila, Fausto
author_sort DeCensi, Andrea
collection PubMed
description OBJECTIVES: To assess Italian medical oncologists’ opinion on the implications of conflict of interest (COI) on medical education, care and research, and to evaluate their direct financial relationships. DESIGN: National cross-sectional survey conducted between March and April 2017 among Italian oncologists. SETTING: Online survey sponsored by the Italian College of Medical Oncology Chiefs through its website. PARTICIPANTS: Italian oncologists who filled out an anonymous questionnaire including 19 items and individual and working characteristics. MAIN OUTCOME MEASURE: The proportion of medical oncologists perceiving COI as an outstanding issue and those receiving direct payments from industry. RESULTS: There were 321 respondents, representing 13% of Italian tenured medical oncologists. Overall, 62% declared direct payments from the pharmaceutical industry in the last 3 years. Sixty-eight per cent felt the majority of Italian oncologists have a COI with industry, but 59% suppose this is not greater than that of other specialties. Eighty-two per cent consider that most oncology education is supported by industry. More than 75% believe that current allocation of industry budget on marketing and promotion rather than research and development is unfair, but 75% consider it appropriate to receive travel and lodging hospitality from industry. A median net profit margin of €5000 per patient enrolled in an industry trial was considered appropriate for the employee institution. Sixty per cent agree to receive a personal fee for patients enrolled in industry trials, but 79% state this should be reported in the informed consent. Over 90% believe that scientific societies should publish a financial report of industry support. Finally, 79% disagree to being a coauthor of an article written by a medical writer when no substantial scientific contribution is made. CONCLUSIONS: Among Italian oncologists COI is perceived as an important issue influencing costs, education, care and science. A more rigorous policy on COI should be implemented.
format Online
Article
Text
id pubmed-6042593
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-60425932018-07-16 Conflict of interest among Italian medical oncologists: a national survey DeCensi, Andrea Numico, Gianmauro Ballatori, Enzo Artioli, Fabrizio Clerico, Mario Fioretto, Luisa Livellara, Virginia Ruggeri, Benedetta Tomirotti, Maurizio Verusio, Claudio Roila, Fausto BMJ Open Ethics OBJECTIVES: To assess Italian medical oncologists’ opinion on the implications of conflict of interest (COI) on medical education, care and research, and to evaluate their direct financial relationships. DESIGN: National cross-sectional survey conducted between March and April 2017 among Italian oncologists. SETTING: Online survey sponsored by the Italian College of Medical Oncology Chiefs through its website. PARTICIPANTS: Italian oncologists who filled out an anonymous questionnaire including 19 items and individual and working characteristics. MAIN OUTCOME MEASURE: The proportion of medical oncologists perceiving COI as an outstanding issue and those receiving direct payments from industry. RESULTS: There were 321 respondents, representing 13% of Italian tenured medical oncologists. Overall, 62% declared direct payments from the pharmaceutical industry in the last 3 years. Sixty-eight per cent felt the majority of Italian oncologists have a COI with industry, but 59% suppose this is not greater than that of other specialties. Eighty-two per cent consider that most oncology education is supported by industry. More than 75% believe that current allocation of industry budget on marketing and promotion rather than research and development is unfair, but 75% consider it appropriate to receive travel and lodging hospitality from industry. A median net profit margin of €5000 per patient enrolled in an industry trial was considered appropriate for the employee institution. Sixty per cent agree to receive a personal fee for patients enrolled in industry trials, but 79% state this should be reported in the informed consent. Over 90% believe that scientific societies should publish a financial report of industry support. Finally, 79% disagree to being a coauthor of an article written by a medical writer when no substantial scientific contribution is made. CONCLUSIONS: Among Italian oncologists COI is perceived as an important issue influencing costs, education, care and science. A more rigorous policy on COI should be implemented. BMJ Publishing Group 2018-06-30 /pmc/articles/PMC6042593/ /pubmed/29961019 http://dx.doi.org/10.1136/bmjopen-2017-020912 Text en © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
spellingShingle Ethics
DeCensi, Andrea
Numico, Gianmauro
Ballatori, Enzo
Artioli, Fabrizio
Clerico, Mario
Fioretto, Luisa
Livellara, Virginia
Ruggeri, Benedetta
Tomirotti, Maurizio
Verusio, Claudio
Roila, Fausto
Conflict of interest among Italian medical oncologists: a national survey
title Conflict of interest among Italian medical oncologists: a national survey
title_full Conflict of interest among Italian medical oncologists: a national survey
title_fullStr Conflict of interest among Italian medical oncologists: a national survey
title_full_unstemmed Conflict of interest among Italian medical oncologists: a national survey
title_short Conflict of interest among Italian medical oncologists: a national survey
title_sort conflict of interest among italian medical oncologists: a national survey
topic Ethics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6042593/
https://www.ncbi.nlm.nih.gov/pubmed/29961019
http://dx.doi.org/10.1136/bmjopen-2017-020912
work_keys_str_mv AT decensiandrea conflictofinterestamongitalianmedicaloncologistsanationalsurvey
AT numicogianmauro conflictofinterestamongitalianmedicaloncologistsanationalsurvey
AT ballatorienzo conflictofinterestamongitalianmedicaloncologistsanationalsurvey
AT artiolifabrizio conflictofinterestamongitalianmedicaloncologistsanationalsurvey
AT clericomario conflictofinterestamongitalianmedicaloncologistsanationalsurvey
AT fiorettoluisa conflictofinterestamongitalianmedicaloncologistsanationalsurvey
AT livellaravirginia conflictofinterestamongitalianmedicaloncologistsanationalsurvey
AT ruggeribenedetta conflictofinterestamongitalianmedicaloncologistsanationalsurvey
AT tomirottimaurizio conflictofinterestamongitalianmedicaloncologistsanationalsurvey
AT verusioclaudio conflictofinterestamongitalianmedicaloncologistsanationalsurvey
AT roilafausto conflictofinterestamongitalianmedicaloncologistsanationalsurvey